ArticleProtoplasma2026
Osmotic stress and melatonin in Pfaffia glomerata: biochemical responses and 20-hydroxyecdysone modulation.
Article in Protoplasma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evolutionary reframing - the case of melatonin.Protoplasma · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osmotic stress, driven by factors such as soil drying and salinization, poses a significant challenge to plant growth and metabolism. Melatonin has shown promising results in alleviating abiotic stress by inducing antioxidant defenses in several species, which is particularly interesting when considering medicinal plants. Thus, this study investigates the physiological and biochemical responses of Brazilian-ginseng (Pfaffia glomerata) to PEG 4000-induced osmotic stress and the mitigating effects of exogenous melatonin. Under osmotic stress, P. glomerata exhibited reduced growth, diminished photosynthetic pigments, and increased reactive oxygen species (ROS) levels, highlighting the detrimental impact of water deficit on plant health. Melatonin, in turn, differentially affected leaves and roots, failing to restore shoot growth while promoting root elongation under osmotic stress. In addition, melatonin increased the activity of antioxidant enzymes, particularly peroxidase (POD), reducing ROS production and membrane damage in the leaves. In roots, PEG only increased catalase (CAT) activity. Osmotic adjustment following melatonin application was also evident through elevated sucrose and proline levels, supporting cell turgor and stress adaptation. Interestingly, osmotic stress increased 20-hydroxyecdysone (20-E) levels in roots; however, this increase occurred independently of melatonin. Therefore, despite the induction of osmotic adjustments and antioxidant defenses, melatonin was unable to reverse the growth restraints caused by osmotic stress in P. glomerata. Furthermore, our findings reveal a complex interplay between osmotic stress, antioxidant defenses, and secondary metabolite production. The insights gained offer potential applications for improving stress resilience and secondary metabolite synthesis in medicinal plants, with implications for sustainable agriculture.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.